Cost-utility analysis is a form of economic analysis used to guide procurement decisions, especially health technology assessment (HTA).
As of January 2005, a figure of £30,000 per QALY is the normal British threshold value. Thus, any health intervention which has an incremental cost of more than £30,000 per additional QALY gained would normally be rejected and any intervention which has an incremental cost of less than or equal to £30,000 per extra QALY gained would be accepted as cost-effective.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Cost-utility analysis".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world